News
1d
MyChesCo on MSNWindtree Advances Istaroxime Toward Global Phase 3 Following Positive Interim Study ResultsWARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has reported encouraging interim results from its ongoing ...
Sarilumab and tocilizumab are equally effective in reducing organ support duration and death in patients who are critically ill with COVID-19.
Istaroxime was added to currently available inotropes and vasopressors in the study - no new safety signals were identified and physiological improvements were consistent with istaroxime responses in ...
Patients with heart failure have significant symptom burden, care needs, and often a progressive course to end-stage disease. Palliative care referrals may be helpful but it is currently unclear when ...
Eight critically ill patients saved through CRRT treatment at Meenakshi Hospital, Thanjavur, showcasing success in advanced therapy for kidney support.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results